333 related articles for article (PubMed ID: 21731723)
1. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
Zimmermann HW; Seidler S; Gassler N; Nattermann J; Luedde T; Trautwein C; Tacke F
PLoS One; 2011; 6(6):e21381. PubMed ID: 21731723
[TBL] [Abstract][Full Text] [Related]
2. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.
Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG
Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684
[TBL] [Abstract][Full Text] [Related]
3. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
[TBL] [Abstract][Full Text] [Related]
4. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
5. Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure.
Xu R; Bao C; Huang H; Lin F; Yuan Y; Wang S; Jin L; Yang T; Shi M; Zhang Z; Wang FS
Sci Rep; 2016 Dec; 6():38714. PubMed ID: 27974825
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease.
Leonard DA; Merhige ME; Williams BA; Greene RS
Coron Artery Dis; 2011 Nov; 22(7):491-6. PubMed ID: 21915051
[TBL] [Abstract][Full Text] [Related]
7. Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B.
Zhang JY; Zou ZS; Huang A; Zhang Z; Fu JL; Xu XS; Chen LM; Li BS; Wang FS
PLoS One; 2011 Mar; 6(3):e17484. PubMed ID: 21390263
[TBL] [Abstract][Full Text] [Related]
8. Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes.
Seidler S; Zimmermann HW; Weiskirchen R; Trautwein C; Tacke F
BMC Gastroenterol; 2012 Apr; 12():38. PubMed ID: 22530792
[TBL] [Abstract][Full Text] [Related]
9. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
10. [Influence of IFN on expression of chemokine receptor CXCR1, CXCR2 and their ligand IL-8 in the patients with chronic hepatitis B].
Bi HJ; Wang J; Huang HS; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):422-5. PubMed ID: 22482416
[TBL] [Abstract][Full Text] [Related]
11. The antagonist of CXCR1 and CXCR2 protects
Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
[TBL] [Abstract][Full Text] [Related]
12. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
[TBL] [Abstract][Full Text] [Related]
13. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.
Bárcena C; Aran G; Perea L; Sanjurjo L; Téllez É; Oncins A; Masnou H; Serra I; García-Gallo M; Kremer L; Sala M; Armengol C; Sancho-Bru P; Sarrias MR
EBioMedicine; 2019 May; 43():513-524. PubMed ID: 31076347
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass.
Chishti AD; Dark JH; Kesteven P; Powell H; Snowden C; Shenton BK; Kirby JA; Baudouin SV
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1162-6. PubMed ID: 11726891
[TBL] [Abstract][Full Text] [Related]
15. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
16. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
18. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.
Qiu Y; Zhu J; Bandi V; Atmar RL; Hattotuwa K; Guntupalli KK; Jeffery PK
Am J Respir Crit Care Med; 2003 Oct; 168(8):968-75. PubMed ID: 12857718
[TBL] [Abstract][Full Text] [Related]
19. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
20. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
